Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...

As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, ...

Brian Hilberdink says he wasn’t looking for a new job when he got the call from Boehringer Ingelheim to join up as their new ...

Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year End 2024 Financial ... by commercial launch activities in the United States, with products anticipated to be available ...

National Dentex Labs ("NDX"), a leading provider of dental prosthetics and innovative laboratory solutions, is pleased to announce the appointment of Dr. Mark Adams as the Company's President. Dr.

A discussion on Texas' cannabis industry, medical marijuana and legislative hurdles. for insights into regulation, patient ...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Christoph Korpus, PhD, MBA, as Chief ...

Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also ...

Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of United ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...